Severe Community-Acquired Pneumonia Caused by Human Adenovirus in Immunocompetent Adults: A Multicenter Case Series

PLoS One. 2016 Mar 11;11(3):e0151199. doi: 10.1371/journal.pone.0151199. eCollection 2016.

Abstract

Background: Severe community-acquired pneumonia (CAP) caused by human adenovirus (HAdV), especially HAdV type 55 (HAdV-55) in immunocompetent adults has raised increasing concerns. Clinical knowledge of severe CAP and acute respiratory distress syndrome induced by HAdV-55 is still limited, though the pathogen has been fully characterized by whole-genome sequencing.

Methods: We conducted a multicentre retrospective review of all consecutive patients with severe CAP caused by HAdV in immunocompetent adults admitted to the Emergency Department Intensive Care Unit of two hospitals in Northern China between February 2012 and April 2014. Clinical, laboratory, radiological characteristics, treatments and outcomes of these patients were collected and analyzed.

Results: A total of 15 consecutive severe CAP patients with laboratory-confirmed adenovirus infections were included. The median age was 30 years and all cases were identified during the winter and spring seasons. HAdV-55 was the most frequently (11/15) detected HAdV type. Persistent high fever, cough and rapid progression of dyspnea were typically reported in these patients. Significantly increased pneumonia severity index (PSI), respiratory rate, and lower PaO2/FiO2, hypersensitive CRP were reported in non-survivors compared to survivors (P = 0.013, 0.022, 0.019 and 0.026, respectively). The rapid development of bilateral consolidations within 10 days after illness onset were the most common radiographic finding, usually accompanied by adjacent ground glass opacities and pleural effusions. Total mortality was 26.7% in this study. Corticosteroids were prescribed to 14 patients in this report, but the utilization rate between survivors and non-survivors was not significant.

Conclusions: HAdV and the HAdV-55 sub-type play an important role among viral pneumonia pathogens in hospitalized immunocompetent adults in Northern China. HAdV should be tested in severe CAP patients with negative bacterial cultures and a lack of response to antibiotic treatment, even if radiologic imaging and clinical presentation initially suggest bacterial pneumonia.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenovirus Infections, Human / diagnosis
  • Adenovirus Infections, Human / drug therapy
  • Adenovirus Infections, Human / pathology*
  • Adenovirus Infections, Human / virology*
  • Adenoviruses, Human / genetics
  • Adenoviruses, Human / isolation & purification
  • Adenoviruses, Human / physiology
  • Adolescent
  • Adult
  • Antiviral Agents / therapeutic use
  • China
  • Community-Acquired Infections / diagnosis
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / pathology*
  • Community-Acquired Infections / virology*
  • DNA, Viral / metabolism
  • Female
  • Genotype
  • Hospitals / statistics & numerical data
  • Humans
  • Immunocompromised Host
  • Intensive Care Units
  • Male
  • Middle Aged
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / pathology*
  • Pneumonia, Viral / virology*
  • Retrospective Studies
  • Severity of Illness Index
  • Young Adult

Substances

  • Antiviral Agents
  • DNA, Viral

Grants and funding

This work was supported by Ministry of Health Public Service Sector funded project (201302017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.